Abstract:Background The global coronavirus disease 2019 (COVID-19) pandemic seriously affected people's lives. We evaluated anxiety and depression among patients with insomnia in northeast China during the first wave and release of COVID-19, providing a basis for the clinical diagnosis and treatment of insomnia. Methods We enrolled 4211 patients with insomnia from January 2016 to February 2020, August 2020 to February 2022, August 2022 to December 2022, and January 2023 to February 2023, from our institution. Sleep quality was evaluated using the Athens Insomnia Scale, Insomnia Severity Index (ISI), and Pittsburgh sleep quality index (PSQI), while mood disorder and fatigue were evaluated using the Hhospital anxiety and depression scale (HAD), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder (GAD-7), and Fatigue Scale-14 (FS-14). Results Insomnia with depression increased in prevalence after COVID-19 compared with before (12.8¬†% vs. 15.3¬†%, P ¬†<¬†0.05), while the age of patients decreased [(50.2¬†¬Ī¬†15.2) vs. (47.5¬†¬Ī¬†16.8), P ¬†<¬†0.05]. The number of patients with insomnia and severe depression increased compared with before COVID-19 (20.3¬†% vs. 25.3¬†%, P ¬† 2¬†years had depression ( P ¬†<¬†0.05). As the epidemic subsided, insomnia increased among young and male patients (young patients: 55.2¬†% vs. 37.0¬†%; male patients: 41¬†% vs. 27.4¬†%, respectively; P ¬†<¬†0.05). The proportion of patients with insomnia with anxiety and depression increased (53.8¬†% vs. 51.8¬†%, P ¬†<¬†0.05), the proportion with moderate to severe anxiety increased (7.6¬†% vs. 13.5¬†%, P ¬†<¬†0.05), and moderate and severe depression decreased (moderate: 25.6¬†% vs. 19.1¬†%, severe: 25.8¬†% vs. 20.3¬†%, P ¬†<¬†0.05, respectively). Middle-aged and elderly patients had higher PQSI scores in sleep latency, habitual sleep efficiency, subjective sleep quality, and use of sleep medications than young patients ( P ¬†<¬†0.05). The PSQI score was positively correlated with the PHQ-9 score ( r ¬†=¬†0.526), GAD-7 score ( r ¬†=¬†0.563), and FS-14 score ( r ¬†=¬†0.316) ( P ¬†<¬†0.05). Limitations The study was single-center, the sample size was small, and assessment data were lacking from early in the epidemic. The scale is subjective, which may affect the accuracy. Conclusion Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2¬†years had depression. The proportion of patients with insomnia with anxiety and depression was higher after the epidemic period, and the degree worsened. The proportion of insomnia with depression decreased after the epidemic period, and the degree alleviated. The proportion of young male patients with insomnia increased. Middle aged and elderly patients with insomnia had poor sleep quality, which was positively correlated with anxiety, depression, and fatigue.

Prevalence of insomnia and its association with quality of life in caregivers of psychiatric inpatients during the COVID-19 pandemic: a network analysis

Prevalence of insomnia and its association with quality of life among Macau residents shortly after the summer 2022 COVID-19 outbreak: A network analysis perspective

Network analysis of comorbid insomnia and depressive symptoms among psychiatric practitioners during the COVID-19 pandemic

Network analysis of depression, anxiety, insomnia and quality of life among Macau residents during the COVID-19 pandemic

Prevalence of Insomnia Symptoms in Older Chinese Adults During the COVID-19 Pandemic: A Meta-Analysis

Night shifts, insomnia, anxiety, and depression among Chinese nurses during the COVID-19 pandemic remission period: A network approach

Association of insomnia disorder with sociodemographic factors and poor mental health in COVID-19 inpatients in China

Depression and anxiety among caregivers of psychiatric patients during the late stage of the COVID-19 pandemic: A perspective from network analysis

Prevalence and Risk Factors of Anxiety, Depression, and Sleep Problems Among Caregivers of People Living With Neurocognitive Disorders During the COVID-19 Pandemic

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

Prevalence of depression and its association with quality of life among guardians of hospitalized psychiatric patients during the COVID-19 pandemic: a network perspective

Network Analysis of Depression, Anxiety, Posttraumatic Stress Symptoms, Insomnia, Pain, and Fatigue in Clinically Stable Older Patients With Psychiatric Disorders During the COVID-19 Outbreak

Linear Regression Analysis of Sleep Quality in People with Insomnia in Wuhan City during the COVID-19 Pandemic

Insomnia, Anxiety, and Depression During the COVID-19 Pandemic: an International Collaborative Study

Depression, anxiety and insomnia in Chinese older adults and their family caregivers during the COVID-19 pandemic: an actor-partner interdependence model approach

Prevalence and network structure of depression, insomnia and suicidality among mental health professionals who recovered from COVID-19: a national survey in China

Survey of Insomnia and Related Social Psychological Factors Among Medical Staff Involved in the 2019 Novel Coronavirus Disease Outbreak

The mediating effect of resilience and COVID-19 anxiety on the relationship between social support and insomnia among healthcare workers: a cross-sectional study

Prevalence of anxiety, depressive and insomnia symptoms among the different groups of people during COVID-19 pandemic: An overview of systematic reviews and meta-analyses.

Nss_a_307996 703..712

The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status